[Fish]

Originally Posted by RaidersOftheCellar

Speaking of misinformation, one thing that you never hear discussed anymore is the success rate of HCQ and zinc. There was an abundance of anecdotal evidence last year that it was a wildly successful treatment. And recently a study emerged which showed that it was greatly effective even in severely ill patients, dramatically improving chances of survival. There were docs in FL last year who reported a near 100% success rate when treating patients before it was severe. Elderly and obese people were getting up and walking out of the hospital in short order.

But, of course, the “experts,” including Fauci and the FDA strongly advised against its use, saying that the data showed an obvious lack of efficacy. They even tried to argue that it was dangerous. A common drug that’s been FDA approved and safely used for 65 years. Based solely upon a study which was later exposed as completely fraudulent. Nevertheless, they caused it to be banned in many states.

Obviously, it had nothing to do with the fact that a full course of HCQ and zinc costs a few bucks while the vaccines have minted 9 new billionaires.

That's not true though. Here's the most recent meta-studies regarding HCQ. These are peer-reviewed meta-studies that examines all available peer-reviewed studies related to HCQ. All posted this year. Take a look.

Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials

This collaborative meta-analysis of 28 published or unpublished RCTs, including 10,319 patients, shows that treatment with HCQ was associated with increased mortality in COVID-19 patients, and there was no benefit from treatment with CQ. No differences were seen across subgroup analyses on patient setting, diagnosis confirmation, control type, publication status, or dose and the between-study heterogeneity was low. For CQ, the number of studies was too small to draw clear conclusions.

This meta-analysis offers useful insights for a challenging health situation. Hundreds of thousands of patients have received HCQ and CQ outside of clinical trials without evidence of their beneficial effects. Public interest is unprecedented, with weak early evidence supporting HCQ’s merits being widely discussed in some media and social networks—despite the unfavorable results by a very large RCT.

The efficacy and safety of hydroxychloroquine for COVID-19 prophylaxis: A systematic review and meta-analysis of randomized trials

Although pharmacologic prophylaxis is an attractive preventive strategy against COVID-19, the current body of evidence failed to show clinical benefit for prophylactic hydroxychloroquine and showed a higher risk of adverse events when compared to placebo or no prophylaxis.